Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Aphria Inc. APHA

Healthcare Drug Manufacturers - Major Cannabis
Aphria, which is headquartered in Ontario, produces and sells medicinal and recreational cannabis. The company operates through retail and wholesale channels in Canada and internationally. Aphria is a main distributor of medical cannabis to Germany and has operations in over 10 countries outside of Canada. However, it does not have exposure to the U.S. CBD or THC markets due to the constraints... see more

Recent & Breaking News (NDAQ:APHA)

Aphria reports strong performance in Q1 2018, including record revenue and grams sold

Canada NewsWire October 13, 2017

New Proposed Federal Tax Plan for Cannabis Underscores Need for Low Cost Producers

Canada NewsWire October 5, 2017

Green Acre Capital Announces Successful Closing of $25 Million Fund I

GlobeNewswire September 28, 2017

Namaste Announces Product Acquisition Agreement With Aphria Inc.

GlobeNewswire September 20, 2017

Canada's Newest Industry is Heading for a Supply Squeeze

PR Newswire September 20, 2017

Aphria Welcomes Ontario Government's Commitment to Providing Safe and Sensible Access to Recreational Cannabis

Canada NewsWire September 8, 2017

Rise of the Mega-Greenhouse: Canada's Top 4 Largest Greenhouse Growers

PR Newswire September 6, 2017

Aphria and Liberty Respond to TMX Group Statement Regarding Regulatory Engagement

Canada NewsWire August 21, 2017

Aphria Announces $11.5 Million Strategic Investment In Scientus Pharma

Canada NewsWire August 15, 2017

Aphria Announces Global Strategic Partnership With Emerging International Leader Nuuvera Corp.

Canada NewsWire August 9, 2017

Billionaires Bet Big On Canada's Newest $22 Billion Market

PR Newswire July 17, 2017

EBITDA increases 181% in the quarter, exceeding $2.8 million

Marketwired July 12, 2017

Aphria Inks Major Wholesale Supply Agreement With Scientus Pharma, Health Canada Licensed Dealer

MarketWire Canada July 4, 2017

Aphria confirms working partnership with LiUNA Local 625

MarketWire Canada June 19, 2017

Sales of Legal Cannabis Products in the North America Accelerating

PR Newswire June 16, 2017

Aphria Launches First Partnership with Major North American Union

MarketWire Canada June 15, 2017

Kitrinor Metals Inc. and Scythian Biosciences Inc. Announce Signing of Business Combination Agreement

GlobeNewswire June 13, 2017

Cannabis ‘buzz’: the Stockhouse Bullboards light up

Stockhouse Editorial June 6, 2017

Canadian Cannabis Investing Insights from the Cannabis Life Conference

Filing Services Canada May 25, 2017

Tetra Bio-Pharma set for cannabinoid collaboration with Panag Pharma

Stockhouse Editorial May 24, 2017